Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4/A:持股變動聲明(修正)-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | SC 13G:超過5%持股股東披露文件-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%)等
Amylyx Pharmaceuticals | SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(3.9%)
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 FONTEYNE PAUL R.
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Firestone Karen
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Zeiher Bernhardt G
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 MILNE GEORGE M JR
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Quimi Daphne
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Quimi Daphne
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 FRATES JAMES M
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Cohen Joshua B
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Mazzariello Gina
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Klee Justin B.
Amylyx Pharmaceuticals | 4:持股變動聲明-高管 Bedrosian Camille L
Amylyx Pharmaceuticals | 4:持股變動聲明-董事 Zeiher Bernhardt G
Amylyx Pharmaceuticals | 3:首次持股聲明-董事 Zeiher Bernhardt G
Amylyx Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Panacea Innovation Limited(6.2%),Panacea Venture Healthcare Fund II, L.P.(6.2%)等
暫無數據